These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2474527)

  • 21. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.
    Tally FP; Snydman DR; Gorbach SL; Malamy MH
    J Infect Dis; 1979 Jan; 139(1):83-8. PubMed ID: 438530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.
    Reeves DS; Holt HA; Phillips I; King A; Miles RS; Paton R; Wise R; Andrews JM
    J Antimicrob Chemother; 1991 Apr; 27(4):469-74. PubMed ID: 1856126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of clindamycin on intraphagocytic Staphylococcus aureus in leukocytes from patients with chronic osteomyelitis].
    Burgaleta C; Velasco GL; Peletier R; Messeguer M; Pernas M
    Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):143-7. PubMed ID: 1576187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment by Bacteroides species of opsonisation and phagocytosis of enterobacteria.
    Jones GR; Gemmell CG
    J Med Microbiol; 1982 Aug; 15(3):351-61. PubMed ID: 6126594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological stabilization of the glycocalyces of 23 strains of five Bacteroides species using specific antisera.
    Lambe DW; Mayberry-Carson KJ; Ferguson KP
    Can J Microbiol; 1984 Jun; 30(6):809-19. PubMed ID: 6386130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of clindamycin with antibacterial defenses of the lung.
    Astry CL; Nelson S; Karam GH; Summer WR
    Am Rev Respir Dis; 1987 May; 135(5):1015-9. PubMed ID: 3579002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
    Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
    J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vivo effects of clindamycin on neutrophil function--a preliminary report.
    Faden H; Hong JJ; Ogra PL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():29-34. PubMed ID: 6643340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An electron microscopic study of the effect of clindamycin therapy on bacterial adherence and glycocalyx formation in experimental Staphylococcus aureus osteomyelitis.
    Mayberry-Carson KJ; Tober-Meyer B; Lambe DW; Costerton JW
    Microbios; 1986; 48(196-197):189-206. PubMed ID: 3796304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
    Mascellino MT; Catania S; De Vito ML; De Bac C
    Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of subminimal inhibitory concentrations of clindamycin and gram-negative aerobic organisms: effects on adhesion and polymorphonuclear leukocyte function.
    Lianou PE; Bassaris HP; Votta EG; Papavassiliou JT
    J Antimicrob Chemother; 1985 Apr; 15(4):481-7. PubMed ID: 4008380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of clindamycin on stimulation of cell adhesion molecules by endotoxins and enterotoxin of Bacteroides fragilis strains].
    Meisel-Mikołajczyk F; Rokosz A; Kot K; Zawidzka E; Malchar C; Nowaczyk M; Górski A
    Med Dosw Mikrobiol; 2001; 53(2):151-60. PubMed ID: 11757424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.
    Katzenmeyer KN; Szott LM; Bryers JD
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined activity of clindamycin and gentamicin on Bacteroides fragilis and other bacteria.
    Okubadejo OA; Allen J
    J Antimicrob Chemother; 1975 Dec; 1(4):403-9. PubMed ID: 812858
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
    Werner H; Heizmann W; Luft G
    Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 May; 28(2):633-7. PubMed ID: 7399680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of clindamycin on fibronectin-staphylococcal interactions.
    Doran JE; Rissing JP
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():75-83. PubMed ID: 6315672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.